| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.36B | +16.4% |
| Cost of Revenue | $2.47B | +17.0% |
| R&D Expense | $1.69B | -11.5% |
| SG&A Expense | $919.1M | +7.2% |
| Operating Income | -$787.3M | +43.7% |
| Pre-tax Income | -$672.2M | +48.1% |
| Income Tax | $25.6M | -8.7% |
| Net Income | -$697.9M | +47.2% |
| EPS (Basic) | -$0.42 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.05B | -41.2% |
| Short-term Investments | $2.33B | +32.1% |
| Accounts Receivable | $1.35B | +5.5% |
| Current Assets | $4.91B | -1.4% |
| Total Assets | $7.94B | -0.4% |
| Current Liabilities | $1.24B | +9.6% |
| Long-term Debt | $3.64B | -2.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $413.5M | +67.7% |
| Capital Expenditures | $194.8M | -8.0% |
| Investing Cash Flow | -$717.1M | -225.6% |
| Financing Cash Flow | -$428.6M | +6.6% |
| Free Cash Flow | $218.7M | +528.4% |
| +48.8% |
| EPS (Diluted) | -$0.42 | +48.8% |
| Total Liabilities |
| $5.49B |
| -1.2% |
| Stockholders' Equity | $2.45B | +1.5% |